4//SEC Filing
Warren Marshelle Smith 4
Accession 0001209191-22-034089
CIK 0001604477other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:39 PM ET
Size
5.4 KB
Accession
0001209191-22-034089
Insider Transaction Report
Form 4
Warren Marshelle Smith
Chief Medical Officer
Transactions
- Award
Stock Option
2022-06-01+200,000→ 200,000 totalExercise: $3.32Exp: 2032-06-01→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the underlying securities on June 1, 2023 and in 36 substantially equal monthly installments thereafter.
Documents
Issuer
SQZ Biotechnologies Co
CIK 0001604477
Entity typeother
Related Parties
1- filerCIK 0001932203
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 4:39 PM ET
- Size
- 5.4 KB